Kolexia
Grosjean Jessica Oncologie médicale
Grosjean Jessica
Oncologie médicale
Selarl D Oncologie Medicale Des Dentellieres
Valenciennes, France
31 Activités
73 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Fatigue Létrozole Tamoxifène Anastrozole Placebo {{person.topmesh8.name}} {{person.topmesh9.name}} {{person.topmesh10.name}}

Collaborateurs

Voir plus
Lauridant Geraldine
Lauridant Geraldine
Clinique Teissier, Valenciennes, France
Jouin Anais
Jouin Anais
Polyclinique Vauban, Valenciennes, France
Vasseur Frédérique
Vasseur Frédérique
Polyclinique Vauban, Valenciennes, France
Lemoine Nathalie
Lemoine Nathalie
Gcs Ghicl Clinique Ste Marie, Cambrai, France

Industries

Voir plus
Janssen
8 collaboration(s)
Dernière en 2023
AstraZeneca
7 collaboration(s)
Dernière en 2023
Pfizer
7 collaboration(s)
Dernière en 2023
Lilly
4 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
EMBER-4: A Randomized, Open-Label, Phase 3 Study of Adjuvant Imlunestrant vs Standard Adjuvant Endocrine Therapy in Patients Who Have Previously Received 2 to 5 Years of Adjuvant Endocrine Therapy for ER+, HER2- Early Breast Cancer With an Increased Risk of Recurrence
Essai Clinique (Lilly)   29 février 2024
QISEIN: Evaluation of the Impact of Taking American Ginseng for 8 Weeks on Fatigue in Patients Treated for Localized Breast Cancer - Randomized, Placebo-controlled, Double-blind Study
Essai Clinique (Centre François-Baclesse)   10 novembre 2023
Feasibility of palbociclib in women aged 70 and older with resistant and/or pretreated advanced breast cancer in the PALOMAGE study
16e Conférence francophone d’Epidémiologie Clinique29è Journées des statisticiens des Centres de Lutte contre le Cancer   01 mai 2022
Abstract P1-18-04: Feasibility of palbociclib in women aged 70 and older with resistant and/or pretreated advanced breast cancer in the PALOMAGE study
2021 San Antonio Breast Cancer Symposium   15 février 2022
Real-world analysis of patients’ clinical and geriatric characteristics aged ≥70 years with advanced breast cancer receiving palbociclib with endocrine therapy in the French cohort PALOMAGE
12th European Breast Cancer Conference (EBCC-12)   01 octobre 2020
KALICOU3: Evaluation of the Impact of Emotional Skills of Young Women (≤ 45 Years), With Non-metastatic Breast Cancer, and Their Partner on Adjustment to Cancer
Essai Clinique (Centre Oscar-Lambret)   24 juin 2019
{{person.lastact7.name}}
{{person.lastact7.jour}}   {{person.lastact7.date}}
{{person.lastact8.name}}
{{person.lastact8.jour}}   {{person.lastact8.date}}
{{person.lastact9.name}}
{{person.lastact9.jour}}   {{person.lastact9.date}}
{{person.lastact10.name}}
{{person.lastact10.jour}}   {{person.lastact10.date}}